Etoposide Plus Benmelstobart Followed by Maintenance Therapy of Benmelstobart Plus Anlotinib in First-line Treatment of Elderly Patients with Extensive Stage Small Cell Lung Cancer: a Single-arm, Prospective Trial

NCT06825208 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Small Cell Lung Cancer Extensive Stage
ELDERLY PEOPLE

Sponsor

Nanjing First Hospital, Nanjing Medical University